These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. The management of fractures in haemophilia and Christmas disease. Kemp HS; Matthews JM J Bone Joint Surg Br; 1968 May; 50(2):351-8. PubMed ID: 5651343 [No Abstract] [Full Text] [Related]
63. Gene therapy for haemophilia: prospects and challenges to prevent or reverse inhibitor formation. Scott DW; Lozier JN Br J Haematol; 2012 Feb; 156(3):295-302. PubMed ID: 22055221 [TBL] [Abstract][Full Text] [Related]
64. Current concepts in diagnosis and management of hemophilia. Aledort LM Hosp Pract (Off Ed); 1982 Oct; 17(10):77-84, 89-92. PubMed ID: 6811410 [No Abstract] [Full Text] [Related]
65. New therapies for hemophilia. Pipe SW Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):650-656. PubMed ID: 27913542 [TBL] [Abstract][Full Text] [Related]
66. The promise of third-generation recombinant therapy and gene therapy. Manno CS Semin Hematol; 2003 Jul; 40(3 Suppl 3):23-8. PubMed ID: 14690065 [TBL] [Abstract][Full Text] [Related]
67. Valoctocogene Roxaparvovec and Etranacogene Dezaparavovec: Novel Gene Therapies for Hemophilia A and B. Dougherty JA; Dougherty KM Ann Pharmacother; 2024 Aug; 58(8):834-848. PubMed ID: 37978816 [TBL] [Abstract][Full Text] [Related]
68. 2017 Clinical trials update: Innovations in hemophilia therapy. Hartmann J; Croteau SE Am J Hematol; 2016 Dec; 91(12):1252-1260. PubMed ID: 27563744 [TBL] [Abstract][Full Text] [Related]
69. Pioneering therapeutic proteins in hemophilia care through innovative technologies. Pabinger-Fasching I; Négrier C Thromb Res; 2016 May; 141 Suppl 3():S1. PubMed ID: 27288062 [No Abstract] [Full Text] [Related]
70. How to manage invasive procedures in children with haemophilia. Ljung RC; Knobe K Br J Haematol; 2012 Jun; 157(5):519-28. PubMed ID: 22390160 [TBL] [Abstract][Full Text] [Related]
71. The current approach to hemophilia. Morrison CJ J Maine Med Assoc; 1974 Sep; 65(9):205-6. PubMed ID: 4416140 [No Abstract] [Full Text] [Related]
72. Prevention of spontaneous bleeding in dogs with haemophilia A and haemophilia B. Nichols TC; Raymer RA; Franck HW; Merricks EP; Bellinger DA; DeFriess N; Margaritis P; Arruda VR; Kay MA; High KA Haemophilia; 2010 May; 16 Suppl 3(Suppl 3):19-23. PubMed ID: 20586797 [TBL] [Abstract][Full Text] [Related]
73. Treatment of hemophiliacs with inhibitors: cost and effect on blood resources. Aledort LM; Cohen M; Hilgartner M; Lipton R Prog Clin Biol Res; 1984; 150():353-65. PubMed ID: 6431439 [No Abstract] [Full Text] [Related]
74. [Management of hemophilia]. Laurian Y Rev Prat; 1989 Dec; 39(30):2669-73. PubMed ID: 2515580 [TBL] [Abstract][Full Text] [Related]
75. Genie in a vector. Gould J Sci Am; 2015 Jan; 312(1):S6-7. PubMed ID: 25597116 [No Abstract] [Full Text] [Related]
76. Preventing bleeds by treatment: new era for haemophilia changing the paradigm. Marijke van den Berg H Haemophilia; 2016 Jul; 22 Suppl 5():9-13. PubMed ID: 27405669 [TBL] [Abstract][Full Text] [Related]
77. Current options and new developments in the treatment of haemophilia. Wong T; Recht M Drugs; 2011 Feb; 71(3):305-20. PubMed ID: 21319868 [TBL] [Abstract][Full Text] [Related]
78. Advances in the care and treatment of children with hemophilia. Manco-Johnson MJ Adv Pediatr; 2010; 57(1):287-94. PubMed ID: 21056743 [No Abstract] [Full Text] [Related]
79. In vivo recovery of factor VIII and factor IX: intra- and interindividual variance in a clinical setting. Björkman S; Folkesson A; Berntorp E Haemophilia; 2007 Jan; 13(1):2-8. PubMed ID: 17212717 [TBL] [Abstract][Full Text] [Related]
80. Comprehensive care of the patient with haemophilia and inhibitors undergoing surgery: practical aspects. Kulkarni R Haemophilia; 2013 Jan; 19(1):2-10. PubMed ID: 22925397 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]